Recognition of the Different Structural Forms of the Capsid Protein Determines the Outcome following Infection with Porcine Circovirus Type 2

Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development

(2012) Pei-Ching Wu et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA

(2012) H.-G. Shen et al.   JOURNAL OF GENERAL VIROLOGY

Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition

(2012) Benjamin R. Trible et al.   VACCINE

Mapping of the nuclear localization signals in open reading frame 2 protein from porcine circovirus type 1

(2011) J. Shuai et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Antibody Recognition of Porcine Circovirus Type 2 Capsid Protein Epitopes after Vaccination, Infection, and Disease

(2011) Benjamin R. Trible et al.   Clinical and Vaccine Immunology

Characterization of a New Disease Syndrome Associated with Porcine Circovirus Type 2 in Previously Vaccinated Herds

(2011) A. G. Cino-Ozuna et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The 2.3-Angstrom Structure of Porcine Circovirus 2

(2011) R. Khayat et al.   JOURNAL OF VIROLOGY

Genetic variation of porcine circovirus type 2 (PCV2) and its relevance to vaccination, pathogenesis and diagnosis

(2011) Benjamin R. Trible et al.   VIRUS RESEARCH

Concurrent infections are important for expression of porcine circovirus associated disease

(2011) Tanja Opriessnig et al.   VIRUS RESEARCH

Feline Immunodeficiency Virus (FIV) Neutralization: A Review

(2011) Margaret J. Hosie et al.   Viruses-Basel

Porcine Reproductive and Respiratory Syndrome Virus Infection at the Time of Porcine Circovirus Type 2 Vaccination Has No Impact on Vaccine Efficacy

(2010) A. Sinha et al.   Clinical and Vaccine Immunology

Post-weaning multisystemic wasting syndrome (PMWS) clinical expression under field conditions is modulated by the pig genetic background

(2010) Sergio López-Soria et al.   VETERINARY MICROBIOLOGY

One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions

(2010) Paolo Martelli et al.   VETERINARY MICROBIOLOGY

PCV-2 genotype definition and nomenclature

(2010) J. Segales et al.   VETERINARY RECORD

Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli

(2010) Shuanghui Yin et al.   Virology Journal

Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?

(2009) Leonidas Stamatatos et al.   NATURE MEDICINE

Porcine circoviruses—Small but powerful

(2009) Tim Finsterbusch et al.   VIRUS RESEARCH

The open reading frame 3 (ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus infection but evidence of reduced pathogenicity is limited in pigs infected by an ORF3-null PCV2 mutant

(2009) N.M. Juhan et al.   VIRUS RESEARCH

Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus

(2008) Lan-Jun Liu et al.   ARCHIVES OF VIROLOGY

A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2

(2008) Kyle P. Horlen et al.   JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION

Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2

(2008) Marion Kixmöller et al.   VACCINE

The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex

(2008) Vicky Fachinger et al.   VACCINE

Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case–control study supports a shift in genotypes with time

(2007) K. Dupont et al.   VETERINARY MICROBIOLOGY